Report Detail
Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography
- RnM3652786 |
- 16 September, 2019 |
- Global |
- 159 Pages |
- The Insight Partners |
- Other
The global cancer tissue diagnostics market is expected to reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.
The market for cancer tissue diagnostics is expected to grow, owing to factors such as growing cancer prevalence across the globe, new product launches & FDA approvals and growing investments for tissue diagnostics are boosting the market over the years. In addition, the emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years. However, factors such as high cost of cancer diagnostics are likely to have a negative impact on the growth of the market in the coming years.
Cancer tissue diagnostic techniques are used to detect the tumor in the malignant tissues. In the last few years, immunohistochemistry (IHC) was used to increase the detection of specific antigens in the tumor tissue. The screening with the help of nonfluorescent chromogens is analyzed with conventional microscopy. There are recent techniques developed for cancer tissue diagnosis. Fluorescence in situ hybridization, the method is used for examination of a specific genetic abnormality in the genome. The hybridized deoxyribonucleic acid (DNA) is examined with particular probes.
The high cost of cancer diagnostics may restrain the growth of the market during the forecast period. Factors such as high costs involved in diagnosis as well as treatment have a restraining effect on the cancer tissue diagnostic market. Cancer diagnostics tests have become so pricey that ordinary people are unable to afford it. High out-of-pocket costs are barriers to potentially life-saving diagnosis or life-prolonging treatments. These sums up to high diagnosis cost, and thus, patients delay or avoid the diagnosis, which results as a barrier to treatment. According to the study by Marten group, the average out-of-pocket cost of a diagnostic mammogram can be $234 on average, while a breast MRI can cost patients $1,021 on average. Therefore, market players need to focus on developing new products that more cost-efficient than the existing ones in the market to gain potential growth.
Global cancer tissue diagnostics market is segmented by test type. On the basis of test type, the market is segmented into immunohistochemical tests and in situ hybridization tests. On the basis of type, immunohistochemical tests are further sub-segmented into breast cancer, colorectal cancer, prostate cancer, stomach cancer, and others. On the basis of type, in situ hybridization tests is further sub-segmented into breast cancer, lung cancer, bladder cancer, and others. In 2018, the breast cancer segment held the largest share in the market, by immunohistochemical tests.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, Public Health Agency of Canada, International Agency for Research on Cancer, Canadian Breast Cancer Foundation, National Cancer Institute (NCI), National Institute of Cancer Prevention and Research (NICPR), Pancreatic Cancer Network South Africa, and others.
TABLE OF CONTENTS
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Cancer Tissue Diagnostics Market - By Test Type
- 1.3.2 Global Cancer Tissue Diagnostics Market - By Geography
2. Global Cancer Tissue Diagnostics Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Global Cancer Tissue Diagnostics Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
5. Global Cancer Tissue Diagnostics Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Growing Cancer Prevalence Across The Globe
- 5.1.2 New Product Launches & FDA Approvals
- 5.1.3 Growing Investments For Tissue Diagnostics
- 5.2 Key Market Restraints
- 5.2.1 High Cost Of Cancer Diagnostics
- 5.3 Key Market Opportunities
- 5.3.1 Emerging Markets in Developing Countries
- 5.4 Future Trends
- 5.4.1 Inclination Towards Personalized Medicine
- 5.5 Impact Analysis
6. Cancer Tissue Diagnostics Market - Global Analysis
- 6.1 Global Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
- 6.2 Global Cancer Tissue Diagnostics Market, By Geography - Forecasts And Analysis
- 6.3 Performance of Key Players
7. Global Cancer Tissue Diagnostics Market Analysis- by Test Type
- 7.1 Overview
- 7.2 Global Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)
- 7.3 Immunohistochemical Tests Market
- 7.3.1 Overview
- 7.3.2 Global Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.3.3 Breast Cancer Market
- 7.3.3.1 Overview
- 7.3.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.3.4 Colorectal Cancer Market
- 7.3.4.1 Overview
- 7.3.4.2 Global Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.3.5 Prostate Cancer Market
- 7.3.5.1 Overview
- 7.3.5.2 Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.3.6 Stomach Cancer Market
- 7.3.6.1 Overview
- 7.3.6.2 Global Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.3.7 Others Market
- 7.3.7.1 Overview
- 7.3.7.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4 In Situ Hybridization Tests Market
- 7.4.1 Overview
- 7.4.2 Global In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.3 Breast Cancer Market
- 7.4.3.1 Overview
- 7.4.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.4 Lung Cancer Market
- 7.4.4.1 Overview
- 7.4.4.2 Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.5 Bladder Cancer Market
- 7.4.5.1 Overview
- 7.4.5.2 Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4.6 Others Market
- 7.4.6.1 Overview
- 7.4.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 - Geographical Analysis
- 8.1 North America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
- 8.1.1 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.1.2 North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.1.2.1 North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.1.2.2 North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.1.3 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
- 8.1.4 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.1.4.1 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.1.4.2 US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.1.4.2 US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.1.4.2 US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.1.5 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.1.5.1 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.1.5.2 Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.1.5.2 Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.1.5.2 Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.1.6 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.1.6.1 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.1.6.2 Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.1.6.2 Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.1.6.2 Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
- 8.2.1 Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.2.2.1 Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.2.2 Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.3 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
- 8.2.4 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.4.1 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.4.2 UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.2.4.2 UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.4.2 UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.5 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.5.1 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.5.2 Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.2.5.2 Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.5.2 Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.6 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.6.1 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.6.2 France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.2.6.2 France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.6.2 France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.7 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.7.1 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.7.2 Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.2.7.2 Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.7.2 Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.8 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.8.1 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.2.8.2 Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.2.8.2 Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.2.8.2 Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027
- 8.3.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.2 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.3.2.1 Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.2.2 Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
- 8.3.4 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.4.1 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.4.2 Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.3.4.2 Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.4.2 Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.5 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.5.1 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.5.2 China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.3.5.2 China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.5.2 China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.6 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.6.1 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.6.2 India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.3.6.2 India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.6.2 India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.7 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.7.1 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.7.2 South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.3.7.2 South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.7.2 South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.8 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.8.1 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.3.8.2 Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.3.8.2 Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.3.8.2 Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
- 8.4.1 Middle East & Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.2 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.4.2.1 Middle East & Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4.2.2 Middle East & Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4.3 Middle East & Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
- 8.4.4 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.4.1 UAE Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.4.2 UAE Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.4.4.2 UAE Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4.4.2 UAE In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4.4.3 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.4.4 Saudi Arabia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.4.5 Saudi Arabia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.4.4.5 Saudi Arabia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4.4.5 Saudi Arabia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4.5 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.5.1 South Africa Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4.5.2 South Africa Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.4.5.2 South Africa Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.4.5.2 South Africa In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.5 South And Central America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
- 8.5.1 South and Central America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.2 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.5.2.1 South and Central America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.5.2.2 South and Central America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.5.3 South and Central America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
- 8.5.4 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.4.1 Argentina Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.4.2 Argentina Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.5.4.2 Argentina Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.5.4.2 Argentina In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.5.4.3 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.4.4 Brazil Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5.4.5 Brazil Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
- 8.5.4.5 Brazil Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
- 8.5.4.5 Brazil In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9. Cancer Tissue Diagnostics Market- Industry Landscape
- 9.1 Overview
- 9.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
- 9.3 Organic Growth Strategies
- 9.3.1 Overview
- 9.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
- 9.4.1 Product Launches
- 9.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market
- 9.4.2 Product Approvals
- 9.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market
- 9.4.3 Expansion & Other Activities
- 9.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
- 9.4.4 Product Enhancements
- 9.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
- 9.4.1 Product Launches
- 9.5 Inorganic Growth Strategies
- 9.5.1 Overview
- 9.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
- 9.6.1 Agreements
- 9.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market
- 9.6.2 Partnerships & Collaborations
- 9.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
- 9.6.3 Acquisitions
- 9.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
10. Cancer Tissue Diagnostics Market-Key Company Profiles
- 10.1 Bio-Rad Laboratories, Inc.
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Financial Information
- 10.1.4 Product Portfolio
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
- 10.2 Thermo Fisher Scientific, Inc.
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Financial Information
- 10.2.4 Product Portfolio
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
- 10.3 F. Hoffmann-La Roche Ltd.
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Financial Overview
- 10.3.4 Product Portfolio
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
- 10.4 Abbott
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Financial Overview
- 10.4.4 Product Portfolio
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
- 10.5 Enzo Biochem Inc.
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Financial Overview
- 10.5.4 Product Portfolio
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
- 10.6 Agilent Technologies, Inc.
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Financial Overview
- 10.6.4 Product Portfolio
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
- 10.7 Cancer Genetics Inc.
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Financial Overview
- 10.7.4 Product Portfolio
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
- 10.8 Merck Kgaa (Sigma-Aldrich)
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Financial Overview
- 10.8.4 Product Portfolio
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
- 10.9 Abcam Plc.
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Financial Overview
- 10.9.4 Product Portfolio
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
- 10.10 Danaher
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Financial Information
- 10.10.4 Product Portfolio
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments
11. Appendix
- 11.1 About The Insight Partners
- 11.2 Glossary Of Terms
- 9.6.1 Agreements
Summary:
Get latest Market Research Reports on Cancer Tissue Diagnostics. Industry analysis & Market Report on Cancer Tissue Diagnostics is a syndicated market report, published as Cancer Tissue Diagnostics Market to 2027 - Global Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Geography. It is complete Research Study and Industry Analysis of Cancer Tissue Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
